Výsledky vyhledávání

Akademický článek

First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure

Autor: Bożena Sikora-Kupis, Piotr Domański, Weronika Fortuniak, Barbara Kruczyk, Szymon Staneta, Mateusz Piętak, Anna Mydlak, Tomasz Demkow, Paulina Dumnicka, Jakub Kucharz

Publikováno v: Contemporary Oncology, Vol 27, Iss 4, Pp 224-229 (2024)

Externí odkaz: https://doaj.org/article/8184961a650e4c538bffa28e775d008b

Zobrazit plný text záznamu

Akademický článek

Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study

Autor: Piotr Domański, Jadwiga Jarosińska, Barbara Kruczyk, Mateusz Piętak, Anna Mydlak, Tomasz Demkow, Łukasz Kuncman, Marta Darewicz, Bożena Sikora-Kupis, Wojciech Michalski, Jakub Kucharz

Publikováno v: Contemporary Oncology, Vol 27, Iss 4, Pp 242-248 (2024)

Externí odkaz: https://doaj.org/article/ac324b6385744488a33d96c85b6e5c03

Zobrazit plný text záznamu

Akademický článek

Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review

Autor: Piotr Domański, Mateusz Piętak, Szymon Staneta, Weronika Fortuniak, Barbara Kruczyk, Adam Kobiernik, Piotr Bakuła, Anna Mydlak, Tomasz Demkow, Bożena Sikora-Kupis, Paulina Dumnicka, Jakub Kucharz

Publikováno v: Medicina, Vol 60, Iss 3, p 398 (2024)

Background and Objectives: More than 430,000 new cases of renal cell carcinoma (RCC) were reported in 2020. Clear cell RCC, which occurs in 80% of cases, is often associated with mutations in the VHL gene, leading to dysregulation of hypoxia-induced

Externí odkaz: https://doaj.org/article/c9ec19aab813401cbe7ae752ffc3dd45

Zobrazit plný text záznamu

Akademický článek

Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study

Autor: Piotr Domański, Mateusz Piętak, Barbara Kruczyk, Jadwiga Jarosińska, Anna Mydlak, Tomasz Demkow, Marta Darewicz, Bożena Sikora-Kupis, Paulina Dumnicka, Wojciech Kamzol, Jakub Kucharz

Publikováno v: Biomedicines, Vol 12, Iss 2, p 413 (2024)

Cabozantinib, an oral inhibitor targeting MET, AXL, and VEGF receptors, has become a key component of a sequential treatment strategy for clear cell renal cell carcinoma (ccRCC). The purpose of this work is to show that effective management of advers

Externí odkaz: https://doaj.org/article/d6dcb467a43f4f549d62dc071e739ee9

Zobrazit plný text záznamu

Relapsing polychondritis in a liver transplant recipient

Autor: Tadeusz Budlewski, Zygmunt Stopa, Bartosz Foroncewicz, Dariusz Sołdacki, Leszek Pączek, Agnieszka Powała, Krzysztof Mucha, Anna Mydlak

Publikováno v: Medicine. 96:e8360

Rationale Relapsing polychondritis (RP) is a multisystemic, progressive disease of unknown etiology characterized by recurrent inflammation and progressive cartilage destruction. It can involve all types of cartilage including ears and nose, tracheob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97d22008c59a33af36cacf5b985a352c
https://doi.org/10.1097/md.0000000000008360

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání